Lv51
1440 积分 2021-11-16 加入
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
1小时前
已关闭
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
3小时前
已完结
The story of amylin: from physiology to therapy
3天前
已完结
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
17天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
17天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
17天前
已完结
From animal testing to in vitro systems: advancing standardization in microphysiological systems
25天前
已完结
Advancing oncology drug development: Innovative approaches to enhance success rates while reducing animal testing
25天前
已完结
Organoid-based 3D in vitro microphysiological systems as alternatives to animal experimentation for preclinical and clinical research
25天前
已完结
Opportunities for reducing animal use in the development of intravitreal biotherapeutics
25天前
已完结
皖公网安备34019202002308
